The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
Open accessAbstract
IMPORTANCE: The CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular disease [prior myocardial infarction, peripheral artery disease, or aortic plaque], age 65-75 years, sex category [female]) is used clinically for stroke risk stratification in atrial fibrillation (AF). Its usefulness in a population of patients with heart failure (HF) is unclear. OBJECTIVE: To investigate whether CHA2DS2-VASc predicts ischemic stroke, thromboembolism, and death in a cohort of patients with HF with and without AF. DESIGN, SETTING, AND POPULATION: Nationwide prospective cohort study using Danish registries, including 42 987 patients (21.9% with concomitant AF) not receiving anticoagulation who were diagnosed as having incident HF during 2000-2012. End of follow-up was December 31, 2012. EXPOSURES: Levels of the CHA2DS2-VASc score (based on 10 possible points, with higher scores indicating higher risk), stratified by concomitant AF at baseline. Analyses took into account the competing risk of death. MAIN OUTCOMES AND MEASURES: Ischemic stroke, thromboembolism, and death within 1 year after HF diagnosis. RESULTS: In patients without AF, the risks of ischemic stroke, thromboembolism, and death were 3.1% (n = 977), 9.9% (n = 3187), and 21.8% (n = 6956), respectively; risks were greater with increasing CHA2DS2-VASc scores as follows, for scores of 1 through 6, respectively: (1) ischemic stroke with concomitant AF: 4.5%, 3.7%, 3.2%, 4.3%, 5.6%, and 8.4%; without concomitant AF: 1.5%, 1.5%, 2.0%, 3.0%, 3.7%, and 7% and (2) all-cause death with concomitant AF: 19.8%, 19.5%, 26.1%, 35.1%, 37.7%, and 45.5%; without concomitant AF: 7.6%, 8.3%, 17.8%, 25.6%, 27.9%, and 35.0%. At high CHA2DS2-VASc scores (≥4), the absolute risk of thromboembolism was high regardless of presence of AF (for a score of 4, 9.7% vs 8.2% for patients without and with concomitant AF, respectively; overall P<.001 for interaction). C statistics and negative predictive values indicate that the CHA2DS2-VASc score performed modestly in this HF population with and without AF (for ischemic stroke, 1-year C statistics, 0.67 [95% CI, 0.65-0.68] and 0.64 [95% CI, 0.61-0.67], respectively; 1-year negative predictive values, 92% [95% CI, 91%-93%] and 91% [95% CI, 88%-95%], respectively). CONCLUSIONS AND RELEVANCE: Among patients with incident HF with or without AF, the CHA2DS2-VASc score was associated with risk of ischemic stroke, thromboembolism, and death. The absolute risk of thromboembolic complications was higher among patients without AF compared with patients with concomitant AF at high CHA2DS2-VASc scores. However, predictive accuracy was modest, and the clinical utility of the CHA2DS2-VASc score in patients with HF remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citationThe Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Self-citationGooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
The Danish National Prescription Registry
Wallach Kildemoes, H., Toft Sørensen, H., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,467
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Statistics in Medicine · doi:10.1002/sim.5958 · Cited by 1,852
Guidelines for the management of atrial fibrillation
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,747
Self-citation2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation
Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., & Kirchhof, P. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.11.003 · Cited by 687
Self-citationWarfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., Ammon, S. E., Graham, S., Sacco, R. L., Mann, D. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202299 · Cited by 584
Self-citationCamm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., Al-Attar, N., Hindricks, G., Prendergast, B., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq512 · Cited by 555
Self-citationValidity of Stroke Diagnoses in a National Register of Patients
Krarup, L.-H., Boysen, G., Janjua, H., Prescott, E., & Truelsen, T. (2007) · Neuroepidemiology · doi:10.1159/000102143 · Cited by 366
Klein, J. P., & Andersen, P. K. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.031209.x · Cited by 349
Analyzing survival curves at a fixed point in time
Klein, J. P., Logan, B., Harhoff, M., & Andersen, P. K. (2007) · Statistics in Medicine · doi:10.1002/sim.2864 · Cited by 315
Moving the Tipping Point: The Decision to Anticoagulate Patients With Atrial Fibrillation
Eckman, M. H., Singer, D. E., Rosand, J., & Greenberg, S. M. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958108 · Cited by 275
Accuracy of a Heart Failure Diagnosis in Administrative Registers
Kümler, T., Gislason, G. H., Kirk, V., Bay, M., Nielsen, O. W., Køber, L., & Torp-Pedersen, C. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.05.006 · Cited by 263
Dunkman, W. B., Johnson, G. R., Carson, P. E., Bhat, G., Farrell, L., & Jn, C. (1993) · PubMed · Cited by 185
Freudenberger, R. S., Hellkamp, A. S., Halperin, J. L., Poole, J., Anderson, J., Johnson, G., Mark, D. B., Lee, K. L., & Bardy, G. H. (2007) · Circulation · doi:10.1161/circulationaha.106.661397 · Cited by 169
Ischemic stroke after heart failure: A community-based study
Witt, B. J., Brown, R. D., Jacobsen, S. J., Weston, S. A., Ballman, K. V., Meverden, R. A., & Roger, V. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.018 · Cited by 162
Mitchell, L. B., Southern, D. A., Galbraith, D., Ghali, W. A., Knudtson, M., & Wilton, S. B. (2014) · Heart · doi:10.1136/heartjnl-2013-305303 · Cited by 161
Heart failure and the risk of stroke: the Rotterdam Study
Alberts, V., Bos, M. J., Koudstaal, P. J., Albert Hofman, D., Witteman, J. C. M., Stricker, B. H. C., & Breteler, M. M. B. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9520-y · Cited by 130
Potpara, T., Polovina, M. M., Licina, M. M., Marinković, J., Prostran, M. S., & Lip, G. Y. H. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966713 · Cited by 117
Self-citationTrend in Mortality after Stroke with Atrial Fibrillation
Frost, L., Andersen, L. V., Vestergaard, P., Husted, S., & Mortensen, L. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.12.027 · Cited by 86
Agarwal, M., Apostolakis, S. Z., Lane, D. A., & Lip, G. Y. H. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.015 · Cited by 74
Self-citationPonikowski, P. P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., Morais, J., Pullicino, P. M., Rasmussen, L., Marín, F. R., Lane, D. A., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0578 · Cited by 74
Self-citationLip, G. Y. H., Lin, H., Chien, K., Hsu, H., Su, T., Chen, M.-F., & Lee, Y. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.148 · Cited by 67
Self-citationLip, G. Y. H., Rasmussen, L. H., Skjøth, F., Overvad, K., & Larsen, T. B. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000975 · Cited by 66
Self-citationStroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
Olesen, J. B., & Torp-Pedersen, C. T. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0154 · Cited by 60
The risks of risk scores for stroke risk assessment in atrial fibrillation
Chao, T., & Nielsen, P. B. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0210 · Cited by 50
Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., & Kirchhof, P. F. (2013) · EP Europace · doi:10.1093/europace/eut040 · Cited by 50
Self-citationTaillandier, S., Olesen, J. B., Clémenty, N., Lagrenade, I., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02257.x · Cited by 42
Self-citationHeart Failure in Very Old Adults
Forman, D. E., Ahmed, A., & Fleg, J. L. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0163-7 · Cited by 30
Jacqmin‐Gadda, H., Blanche, P., Chary, E., Loubère, L., Amieva, H., & Dartigues, J. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu202 · Cited by 24
Accuracy of a heart failure diagnosis in administrative registers
KUMLER, T., Gislason, G., Kirk, V., BAY, M., Nielsen, O. W., Køber, L., & TORPPEDERSEN, C. (2008) · European Journal of Heart Failure Supplements · doi:10.1016/s1567-4215(08)60430-0 · Cited by 14
Female sex is associated with a lower risk of stroke in patients with heart failure
Melgaard, L., Gorst‐Rasmussen, A., Lip, G. Y. H., Rasmussen, L. H., & Larsen, T. B. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.12.004 · Cited by 5
Self-citation
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.011 · Cited by 931
Prosthetic Heart Valve Thrombosis
Dangas, G. D., Weitz, J. I., Giustino, G., Makkar, R., & Mehran, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.958 · Cited by 502
Metadata
- Authors
- Melgaard, L., Gorst-Rasmussen, A., Lane, D. A., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-09-08
- Volume
- 314
- Issue
- 10
- Pages
- 1030
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1945494843
- Cited by
- 315
- References
- 37
- FWCI
- 22.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.